CD8A and neoplasm: At early stages of elimination, the enhanced production of neo-antigens by cancer cells, as an inevitable result of their enhanced genetic instability [17], leads to their capture by antigen-presenting cells, specifically dendritic cells (DCs), which leave the tumor microenvironment and migrate to the lymph nodes, inducing the activation of tumor-specific and cytotoxic CD8+ T cells.